Literature DB >> 29263047

Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells.

Zexin Li1, Xitao Li1, Shaoda Lin1, Yongsong Chen1, Shuhua Ma1, Yucai Fu2, Chiju Wei3, Wencan Xu4.   

Abstract

OBJECTIVES: We found that activation of the nicotinic acid receptor GPR109A, expressed by the MIN6 murine pancreatic β cell line, inhibits nitric oxide accumulation induced by IFN-γ and TNF-α, implicating an anti-inflammatory effect of GPR109A in MIN6 cells. Nevertheless, the mechanism of its anti-inflammatory effect is still unknown. In this study, we used palmitic acid to stimulate MIN6 cells to induce inflammatory cytokine production and explored the mechanism by which GPR109A exerts anti-inflammatory effects.
MATERIALS AND METHODS: RT-PCR and immunocytochemical staining were used to detect the expression of GPR109A in MIN6 cells. Western blotting was used to detect the activation of the Akt/mTOR signaling pathway and expression of the inflammatory cytokine INF-γ, in MIN6 cells, following treatments with palmitic acid and palmitic acid+nicotinic acid, or with different concentrations of nicotinic acid and 3-hydroxybutyrate.
RESULTS: In MIN6 cells, GPR109A transcripts and protein are expressed and GPR109A protein is mainly located in the cell membrane and cytoplasm. Palmitic acid enhanced the phosphorylation of Akt and p70S6K and elevated the expression of IFN-γ. Co-treatment with nicotinic acid, which is an agonist of GPR109A, inhibited the palmitic acid-induced phosphorylation of Akt, mTOR, and p70S6K, as well as the expression of IFN-γ.
CONCLUSIONS: GPR109A may inhibit inflammatory cytokine production, induced by palmitic acid, by MIN6 cells possibly via inhibiting the Akt/mTOR signaling pathway.
© 2017 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  GPR109A; inflammation; palmitic acid

Mesh:

Substances:

Year:  2017        PMID: 29263047

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  5 in total

1.  Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate.

Authors:  Yinji Liang; Chenli Lin; Yupei Zhang; Yuanjun Deng; Chan Liu; Qinhe Yang
Journal:  Inflammopharmacology       Date:  2018-04-10       Impact factor: 4.473

Review 2.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

Review 3.  Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism.

Authors:  Jin He; Peiwen Zhang; Linyuan Shen; Lili Niu; Ya Tan; Lei Chen; Ye Zhao; Lin Bai; Xiaoxia Hao; Xuewei Li; Shunhua Zhang; Li Zhu
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

Review 4.  The Association between Gut Microbiota and Osteoarthritis: Does the Disease Begin in the Gut?

Authors:  Luciano C Ramires; Gabriel Silva Santos; Rafaela Pereira Ramires; Lucas Furtado da Fonseca; Madhan Jeyaraman; Sathish Muthu; Anna Vitória Lana; Gabriel Azzini; Curtis Scott Smith; José Fábio Lana
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

5.  Niacin Alleviates Dairy Cow Mastitis by Regulating the GPR109A/AMPK/NRF2 Signaling Pathway.

Authors:  Wenjin Guo; Juxiong Liu; Wen Li; He Ma; Qian Gong; Xingchi Kan; Yu Cao; Jianfa Wang; Shoupeng Fu
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.